中毒性心肌病的机制
本文为综述,检索PubMed 1980年至2017年12月文献,最终纳入92篇关于中毒性心肌病病理生理机制(动物模型或临床实践)的论文。综述了蒽环类、曲妥珠单抗、伊马替尼、齐多夫定、噻唑烷二酮类、可卡因、乙醇、甲基苯丙胺、一氧化碳、金属(钴、锑、汞、锂)及蝎毒等导致心肌病的机制。核心机制包括干扰心肌细胞生物能量学和细胞内钙处理、活性氧生成、神经激素应激及诱导凋亡。临床意义在于诊断特发性心肌病前须排除中毒病因。
要点
- 诊断特发性心肌病前,临床医生不仅须排除病毒和免疫病因,还须排除药物、环境因素、非法物质和天然毒素等中毒病因。
- 蒽环类心脏毒性机制主要与其抗癌作用机制相关,主要是抑制拓扑异构酶IIβ和DNA切割,代谢或氧化应激因素及铁代谢干扰可能也起作用。
- 齐多夫定因线粒体毒性而具有心脏毒性,除能量耗竭外还增加线粒体活性氧生成。
- 可卡因相关心脏毒性涉及多种机制,其中交感神经过度刺激伴心肌氧耗增加在急性左心室功能障碍中已充分证实。
- 一氧化碳除缺氧损伤外还直接对线粒体有毒,在细胞色素c氧化酶水平损害线粒体呼吸链,降低谷胱甘肽浓度和ATP生成;急性暴露幸存者中无证据支持迟发性扩张型心肌病。
适用人群与场景
- 诊断特发性心肌病前须排除病毒、免疫及中毒病因(药物、环境因素、非法物质、天然毒素)的患者。
研究设计与关键结果
- 综述检索PubMed 1980年至2017年12月,初筛339篇,最终纳入92篇涉及中毒性心肌病病理生理机制(动物模型或临床实践)的论文,优先选择较近期发表的论文。
- 蒽环类心脏毒性机制主要与其抗癌作用机制相关,主要为抑制拓扑异构酶IIβ和DNA切割,代谢或氧化应激因素及铁代谢干扰可能参与。
- 曲妥珠单抗和伊马替尼也影响应激通路。
- 齐多夫定因线粒体毒性而具心脏毒性,除能量耗竭外还增加线粒体活性氧生成。
- 噻唑烷二酮类抗糖尿病药的心脏毒性仍在研究中,怀疑与干扰线粒体呼吸或氧化应激有关。
- 可卡因相关心脏毒性涉及多种机制,交感神经过度刺激伴心肌氧耗增加在急性左心室功能障碍中已充分证实;可卡因相关心肌病中凋亡和活性氧的作用仍在研究中。
- 乙醇相关心脏毒性病因是多因素的,个体易感性重要,涉及凋亡、心肌细胞兴奋-收缩耦联改变、线粒体和肌浆网结构与功能改变、胞质钙流改变、肌丝钙敏感性改变、线粒体氧化改变、蛋白合成失调、收缩蛋白减少、不同肌原纤维类型比例失调、肌球蛋白ATP酶调节改变、L型钙通道上调、氧化应激增加及心室心肌ANP和p21 mRNA表达诱导。
- 甲基苯丙胺的可能原因是儿茶酚胺介导的毒性,遗传易感性可能起作用。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 诊断特发性心肌病前,临床医生须排除病毒和免疫病因,也须排除药物、环境因素、非法物质和天然毒素等中毒病因。
- 作者认为中毒性心肌病机制复杂多因素,包括干扰心肌细胞生物能量学和细胞内钙处理、活性氧生成、神经激素应激及诱导凋亡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Dilated cardiomyopathy is a frequent disease responsible for 40-50% of cases of heart failure. Idiopathic cardiomyopathy is a primary disorder often related to familial/genetic predisposition. Before the diagnosis of idiopathic cardiomyopathy is made, clinicians must not only rule out viral and immune causes, but also toxic causes such as drugs, environmental agents, illicit substances and natural toxins.
OBJECTIVE: The objective of this review is to present recent data on the mechanisms underlying toxic cardiomyopathy.
METHODS: The US National Library of Medicine Pubmed database was searched from 1980 to December 2017 utilizing the combinations of the search terms "toxic cardiomyopathy", "drugs", "anticancer drugs", "azidothymidine", "rosiglitazone", "carbon monoxide", "alcohol", "illicit drugs", "cocaine", "metamfetamine", "metals", "venom". A total of 339 articles were screened and papers that dealt with the pathophysiology of toxic cardiomyopathy, either in animal models or in clinical practice were selected, with preference being given to more recently published papers, which left 92 articles. Anticancer drugs: The mechanisms of anthracycline-induced cardiotoxicity are primarily related to their mechanisms of action as anticancer drugs, mainly the inhibition of topoisomerase II β and DNA cleavage. Additional metabolic or oxidative stress factors may play a part, together with interference with iron metabolism. The more recent drugs, trastuzumab and imatinib, also influence stress pathways. Antiretroviral agents: Azidothymidine is cardiotoxic as a result of mitochondrial toxicity. In addition to energy depletion, azidothymidine also increases the production of mitochondrial reactive oxygen species (ROS). Antidiabetic drugs: The cardiotoxicity of thiazolidinedione antidiabetic drugs is still under investigation, though interference with mitochondrial respiration or oxidative stress is suspected. Cocaine: Among the multiple mechanisms involved in cocaine-related cardiotoxicity, excessive sympathetic stimulation with increased myocardial oxygen consumption is well documented in the acute form of left ventricular dysfunction. As for cocaine-related cardiomyopathy, the role of apoptosis and ROS is under investigation. Ethanol: The aetiology of ethanol-related cardiotoxicity is multifactorial, with individual susceptibility being important. It involves apoptosis, alterations of the excitation-contraction coupling in cardiac myocytes, structural and functional alterations of the mitochondria and sarcoplasmic reticulum, changes in cytosolic calcium flows, changes in calcium sensitivity of myofilaments, alterations of mitochondrial oxidation, deregulation of protein synthesis, decrease of contractile proteins and disproportion between the different types of myofibrils, changes in the regulation of myosin ATPase, up-regulation of the L-type calcium channels, increase of oxidative stress, and induction of ANP and p21 mRNA expression in ventricular myocardium. Metamfetamines: Catecholamine-mediated toxicity is the probable cause, with a possible role for genetic susceptibility. Carbon monoxide: In addition to hypoxic injury, carbon monoxide is also directly toxic to the mitochondria, with impairment of mitochondrial respiratory chain at the cytochrome c oxidase level, decrease of glutathione concentrations and of ATP production. There is no evidence for a delayed dilated cardiomyopathy in survivors of an acute exposure. Metals: Cobalt-related cardiomyopathy probably results from interference with energy production and contractile mechanisms, but additional factors (nutrition, hypothyroidism) are often required. Antimony may cause lethal oxidative stress and cell death mediated by elevation in intra-cellular calcium. Proposed mechanisms for mercury toxicity include glutathione depletion, production of ROS, and interruption in selenium-dependent endogenous enzymatic reactions. The existence of a lithium-induced cardiomyopathy is still debated. Scorpion venom: Catecholamine release is the probable cause of acute cardiomyopathy following scorpion envenomation.
CONCLUSIONS: The mechanisms behind toxic cardiomyopathy are complex and multifactorial but include interference with myocardial cell bioenergetics and intracellular calcium handling, the generation of ROS, neurohormonal stress, and induction of apoptosis.
参考来源
- Hantson P. Mechanisms of toxic cardiomyopathy. Clin Toxicol (Phila). 2018. PMID: 30260248. doi:10.1080/15563650.2018.1497172
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。